Abstract
A series of novel pyrrolocarbazole lactams was identified as potent PARP-1 inhibitors in vitro and in a PC12 cellular NAD(+) depletion assay. The SAR trends of substituents at the 3-position, as well as the effect of blocking the indole or lactam NH-groups of the template by methylation or formylation, are discussed in relation to molecular modeling studies.
MeSH terms
-
Animals
-
Carbazoles / chemical synthesis
-
Carbazoles / chemistry*
-
Carbazoles / pharmacology*
-
Cell Membrane Permeability / drug effects
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology*
-
Imides / chemistry
-
Inhibitory Concentration 50
-
Lactams / chemical synthesis
-
Lactams / chemistry*
-
Lactams / pharmacology*
-
Models, Molecular
-
PC12 Cells
-
Poly(ADP-ribose) Polymerase Inhibitors*
-
Poly(ADP-ribose) Polymerases / chemistry
-
Poly(ADP-ribose) Polymerases / metabolism
-
Protein Structure, Tertiary
-
Pyrroles / chemical synthesis
-
Pyrroles / chemistry*
-
Pyrroles / pharmacology*
-
Rats
-
Structure-Activity Relationship
Substances
-
Carbazoles
-
Enzyme Inhibitors
-
Imides
-
Lactams
-
Poly(ADP-ribose) Polymerase Inhibitors
-
Pyrroles
-
Poly(ADP-ribose) Polymerases